DHR — Danaher Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual income statement for Danaher, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	22,284	24,802	26,643	23,890	23,875
Cost of Revenue
Gross Profit	12,475	15,239	16,188	14,034	14,231
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	17,624	18,516	19,016	18,657	19,012
Operating Profit	4,660	6,286	7,627	5,233	4,863
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	4,495	6,511	7,146	5,044	4,646
Provision for Income Taxes
Net Income After Taxes	3,646	5,447	6,328	4,221	3,899
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	3,646	6,433	7,209	4,764	3,899
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	3,511	6,347	7,123	4,743	3,899
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4.33	7.42	8.37	5.9	5.68
Dividends per Share